Function and disease susceptibility of bovine MHC class II molecule
牛MHC II类分子的功能和疾病易感性
基本信息
- 批准号:09660334
- 负责人:
- 金额:$ 2.43万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
To investigate the relationship between polymorphism of bovine lymphocyte antigen (BoLA) gene and resistance or susceptibility to BLV-induced lymphoma, exon 2 of the BoLA-DRB3 gene which is highly polymorphic was cloned from 54 BLV-infected animals with 3 independent stages such as an aleukemic healthy, persistent lymphocytosis and lymphoma, and the nucleotide sequences were determined. Sequence analysis revealed that the BoLA-DRB3 alleles encoding Val at position 78 may be associated with resistance to BLV-induced lymphoma. Alleles encoding Val at position 78 were characterized by Arg or Lys, which represent a positive charge at position 71 and by Glu, which represents a negative charge at position 74. By contrast, alleles encoding Tyr at position 78, have amino acids such as Ala, Asn or Tyr, which represent a neutral charge at position 74 and were associated with susceptibility to lymphoma.Next, to confirm the association between polymorphism of MHC class II gene and leukemia, we infected 28 sheep with BLV.Among the 16 sheep with lymphoma, 38% carry specific alleles of the ovine leukocyte antigen (OLA)-DRB1 Arg^<70>-Lys^<71> (RK) as compared to 83% among the 12 BLV-infected sheep at the asymptomatic stage. To analyze the immunoreaction of sheep with allele of OLA-DRB1 RK, we immunized sheep carrying either a RK/X genotype or a X/X genotype with a mixture of synthetic multiple antigenic peptides of T-helper, T-cytotoxic, and B-cell epitopes of BLV envelope glycoprotein gp 51, and two weeks after the last immunization, all sheep were challenged with blood from a BLV-infected sheep. Sheep carrying resistant allele showed high immunoresponse against the mixed peptides and did not proceeded to ieukemia. Our results indicate that difference of immunoresponse resulted due to difference of MHC class II alleles and involved the risk of BLV-induced leukemogenesis.
研究牛淋巴细胞抗原(BOLA)基因的多态性与BLV诱导的淋巴瘤的耐药性或易感性,Bola-DRB3基因的外显子2,这是高度多态性的,从54个BLV感染的动物中克隆了54个BLV感染的动物。确定核苷酸序列。序列分析表明,在78位置编码Val的Bola-DRB3等位基因可能与对BLV诱导的淋巴瘤的抗性有关。编码Val在78处编码Val的等位基因的特征是ARG或LYS,代表位置71和GLU的正电荷,GLU代表位置74处的负电荷。相比之下,编码Tyr在78位置的等位基因,具有ALA,ASN或TYR等氨基酸的等位基因,如74的位置和MISSISS II均与lymphibility succents ii nepribistion.Minsive.Snextibles.s nemply.s相关性。 Gene和Leukemia,我们用Blv.Among感染了28只绵羊,其中16只绵羊带有淋巴瘤,其中38%带有卵子白细胞抗原(OLA)-DRB1 arg^<70> -lys^<71>(RK)的特定等位基因,而在12 blv又是在AS-AS-AS-ASPENS-PENCEMPTAMES中的83%。 To analyze the immunoreaction of sheep with allele of OLA-DRB1 RK, we immunized sheep carrying either a RK/X genotype or a X/X genotype with a mixture of synthetic multiple antigenic peptides of T-helper, T-cytotoxic, and B-cell epitopes of BLV envelope glycoprotein gp 51, and two weeks after the last immunization, all sheep受到BLV感染的绵羊的血液的挑战。携带抗药性等位基因的绵羊对混合肽表现出很高的免疫响应,并且没有进入Ieukemia。我们的结果表明,由于MHC II类等位基因的差异,导致免疫激素的差异,并涉及BLV诱导的白血病的风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Inabe K.,et al.: "The YXXL sequences of bovineleukemia virus transmembraneprotein are required formaintenance of viral penetration andincorporation of viral envelopeprotein into virion." J.Virology. 73. 1293-1301 (1999)
Inabe K.等人:“牛白血病病毒跨膜蛋白的 YXXL 序列是维持病毒渗透和将病毒包膜蛋白掺入病毒粒子所必需的。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Inabe K., Nishizawa M.and Aida Y.: "The YXXL sequences of bovine leukemia virus transmembrane protein are required for maintenance of viral penetration and incorporation of viral envelope protein into virion." J.Virology.73. 1293-1301 (1999)
Inabe K.、Nishizawa M.和 Aida Y.:“牛白血病病毒跨膜蛋白的 YXXL 序列是维持病毒渗透和将病毒包膜蛋白掺入病毒粒子所必需的。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tajima S.,et al.: "Complete bovine leukemia virus (BLV) provirus is conserved in BLV-infected cattle throughout the course of B-cell lymphosarcoma." J.Virology. 243. 235-246 (1998)
Tajima S. 等人:“在 B 细胞淋巴肉瘤的整个病程中,完整的牛白血病病毒 (BLV) 原病毒在 BLV 感染的牛中得到保留。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tajima S., Zhuang, W., Kato MV., Okada K., Ikawa Y.and Aida Y.: "Function and conformation of wild-type p53 protein are influenced by mutations in bovine leukemia virus-induced B-cell lymphosarcoma." Virology. 243. 235-246 (1998)
Tajima S.、Zhong, W.、Kato MV.、Okada K.、Ikawa Y.和 Aida Y.:“野生型 p53 蛋白的功能和构象受到牛白血病病毒诱导的 B 细胞淋巴肉瘤突变的影响。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Inabe K.,et al.: "Transmission and propagation in cell culture of virus produced by cell transfected with an infectious molecular clone of bovine leukemia virus." Virology. 245. 53-64 (1998)
Inabe K.等人:“用牛白血病病毒感染性分子克隆转染的细胞产生的病毒在细胞培养物中的传播和繁殖。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AIDA Yoko其他文献
AIDA Yoko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AIDA Yoko', 18)}}的其他基金
Clinical application of diagnosis method of bovine major histocompatibility complex genes associated with resistanceand susceptibility to bovine leukemia virus-induced lymphomain East Asia
牛主要组织相容性复合体基因与牛白血病病毒东亚淋巴瘤耐药和易感相关的诊断方法的临床应用
- 批准号:
22405040 - 财政年份:2010
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Clinical application of diagnosis method of bovine major histocompatibility complex genes associated with resistance and susceptibility to bovine leukemia virus-induced lymphoma in South America
南美洲牛主要组织相容性复合体基因与牛白血病病毒淋巴瘤耐药和易感性相关的诊断方法的临床应用
- 批准号:
18255013 - 财政年份:2006
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Study on functions of HEV-1 accessory gene Vpr
HEV-1辅助基因Vpr的功能研究
- 批准号:
16017304 - 财政年份:2004
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Genome analysis of bovine major histocompatibility complex region and development of cattle with resistance to disease
牛主要组织相容性复合体区域基因组分析及牛抗病能力的培养
- 批准号:
14206035 - 财政年份:2002
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Detection of bovine MHC genes associated with resistance or susceptibility to bovine leukemia virus-induced lymphoma
牛MHC基因的检测与牛白血病病毒诱导的淋巴瘤的抗性或易感性相关
- 批准号:
13556055 - 财政年份:2001
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Structure, function and disease susceptibility of bovine MHC class II molecules
牛MHC II类分子的结构、功能和疾病易感性
- 批准号:
11460140 - 财政年份:1999
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Detection of cattle associated with resistance or susceptibility to bovine leukemia virus-induced kymphoma by analysis of polymorphism of the bovine MHC genes
通过牛 MHC 基因多态性分析检测牛对牛白血病病毒诱发的鸡肿瘤的抵抗或易感性
- 批准号:
11556061 - 财政年份:1999
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
相似国自然基金
结构变异基因PTHLH抑制MHC-II类分子促进食管鳞癌免疫逃逸的机制研究
- 批准号:82302916
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于II型萜类合酶的基因组挖掘细菌中高氧化度萜类天然产物
- 批准号:
- 批准年份:2020
- 资助金额:56 万元
- 项目类别:面上项目
新型嗜热基因组编辑系统的构建及研究
- 批准号:31760318
- 批准年份:2017
- 资助金额:38.0 万元
- 项目类别:地区科学基金项目
半滑舌鳎抗哈维氏弧菌病关键基因的鉴定及功能分析
- 批准号:31702373
- 批准年份:2017
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
灰眉岩鹀MHC-II类基因在血液寄生虫选择压力下的适应性进化研究
- 批准号:31772444
- 批准年份:2017
- 资助金额:61.0 万元
- 项目类别:面上项目
相似海外基金
Comprehensive characterization of immune signaling networks in single-cells by joint quantification of proteins, protein complexes and mRNA
通过蛋白质、蛋白质复合物和 mRNA 的联合定量来全面表征单细胞中的免疫信号网络
- 批准号:
10636695 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
Characterization of T cells in MOG antibody-associated disease
MOG 抗体相关疾病中 T 细胞的表征
- 批准号:
10737097 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
Characterization of disulfide modified diabetogenic neoepitopes
二硫键修饰的糖尿病新表位的表征
- 批准号:
10720644 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
Non-canonical epitope presentation and antigen processing by MHC-E
MHC-E 的非典型表位呈递和抗原加工
- 批准号:
10801509 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
Immunoepigenetic targeting of MHC regulators in FAP
FAP 中 MHC 调节因子的免疫表观遗传学靶向
- 批准号:
10677375 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别: